BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Jansen I, Hendriksz TR, Han SH, Huiskes AW, van Bommel EF. (18)F-fluorodeoxyglucose position emission tomography (FDG-PET) for monitoring disease activity and treatment response in idiopathic retroperitoneal fibrosis. Eur J Intern Med. 2010;21:216-221. [PMID: 20493425 DOI: 10.1016/j.ejim.2010.02.008] [Cited by in Crossref: 48] [Cited by in F6Publishing: 40] [Article Influence: 4.0] [Reference Citation Analysis]
Number Citing Articles
1 Dondi F, Albano D, Giubbini R, Bertagna F. PET in idiopathic retroperitoneal fibrosis. Nuclear Medicine and Molecular Imaging 2022. [DOI: 10.1016/b978-0-12-822960-6.00059-4] [Reference Citation Analysis]
2 Fenaroli P, Maritati F, Vaglio A. Into Clinical Practice: Diagnosis and Therapy of Retroperitoneal Fibrosis. Curr Rheumatol Rep 2021;23:18. [PMID: 33569638 DOI: 10.1007/s11926-020-00966-9] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 7.0] [Reference Citation Analysis]
3 Shaikh S. PET-CT in Urological Infections and Inflammations. PET-CT in Infection and Inflammation 2021. [DOI: 10.1007/978-981-15-9801-2_17] [Reference Citation Analysis]
4 Sheth R, Malik D. Bilateral Hydronephrosis From Retroperitoneal Fibrosis. Cureus 2020;12:e12147. [PMID: 33489559 DOI: 10.7759/cureus.12147] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
5 Raglianti V, Rossi GM, Vaglio A. Idiopathic retroperitoneal fibrosis: an update for nephrologists. Nephrol Dial Transplant 2020:gfaa083. [PMID: 33005943 DOI: 10.1093/ndt/gfaa083] [Cited by in Crossref: 11] [Cited by in F6Publishing: 13] [Article Influence: 5.5] [Reference Citation Analysis]
6 Le Joncour A, Saadoun D, Cacoub P. La fibrose rétropéritonéale idiopathique. Rev Med Interne 2020;41:822-8. [PMID: 32727694 DOI: 10.1016/j.revmed.2020.06.013] [Reference Citation Analysis]
7 van Baalen EA, Hendriksz TR, Brans B, Westenend PJ, van Bommel EFH. Intimal angiosarcoma masquerading as retroperitoneal fibrosis. Vasa 2021;50:240-3. [PMID: 32657231 DOI: 10.1024/0301-1526/a000889] [Reference Citation Analysis]
8 Gao W, Ou TW, Cui X, Wu JT, Cui B. Metallic ureteral stent in restoring kidney function: Nine case reports. World J Clin Cases 2020; 8(13): 2841-2848 [PMID: 32742993 DOI: 10.12998/wjcc.v8.i13.2841] [Reference Citation Analysis]
9 Nguyen TV, Bader NM, Sidhu H, Cadacio C, Mendoza SM, Pham PTT, Pham PCT. Acute Kidney Failure in a Young African American Male. Case Rep Nephrol 2019;2019:2591560. [PMID: 30911422 DOI: 10.1155/2019/2591560] [Reference Citation Analysis]
10 Morin G, Mageau A, Benali K, Bertinchamp R, Piekarski E, Raimbourg Q, Alexandra JF, Goulenok T, van Gysel D, Papo T, Sacre K. Persistent FDG/PET CT uptake in idiopathic retroperitoneal fibrosis helps identifying patients at a higher risk for relapse. Eur J Intern Med 2019;62:67-71. [PMID: 30711361 DOI: 10.1016/j.ejim.2019.01.019] [Cited by in Crossref: 9] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
11 Hiroi A, Matsumoto M, Takamatsu S, Hayashi K, Yamamoto M, Morishita R, Yanagawa K, Kawarabayashi T. Usefulness of abdominal ultrasonography for diagnosis and follow-up treatment with IgG4-related periaortitis/periarteritis. Jpn J Med Ultrasonics 2019;46:453-459. [DOI: 10.3179/jjmu.jjmu.a.143] [Reference Citation Analysis]
12 Palmisano A, Maritati F, Vaglio A. Chronic Periaortitis: an Update. Curr Rheumatol Rep 2018;20. [DOI: 10.1007/s11926-018-0789-2] [Cited by in Crossref: 14] [Cited by in F6Publishing: 10] [Article Influence: 3.5] [Reference Citation Analysis]
13 Kalisz K, Partovi S. Diffusion-weighted MR in chronic periaortitis, a new technique has entered the clinical arena. Int J Cardiovasc Imaging 2018;34:1787-1788. [DOI: 10.1007/s10554-018-1458-2] [Reference Citation Analysis]
14 Kamper L, Dreger NM, Brandt AS, Pöppel T, Abanador-kamper N, Roth S, Haage P. Diffusion-weighted MRI and PET–CT in the follow up of chronic periaortitis. Int J Cardiovasc Imaging 2018;34:1779-85. [DOI: 10.1007/s10554-018-1395-0] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
15 Accorsi Buttini E, Maritati F, Vaglio A. [ 18 F]-Fluorodeoxyglucose Positron Emission Tomography and Response to Therapy in Idiopathic Retroperitoneal Fibrosis. European Urology 2018;73:145-6. [DOI: 10.1016/j.eururo.2017.09.024] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 3.5] [Reference Citation Analysis]
16 Wang Y, Guan Z, Gao D, Luo G, Li K, Zhao Y, Wang X, Zhang J, Jin J, Zhao Z, Yang C, Zhang J, Zhu J, Huang F. The value of 18F-FDG PET/CT in the distinction between retroperitoneal fibrosis and its malignant mimics. Semin Arthritis Rheum 2018;47:593-600. [PMID: 28958769 DOI: 10.1016/j.semarthrit.2017.07.011] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 3.6] [Reference Citation Analysis]
17 Fernando A, Pattison J, Horsfield C, D’cruz D, Cook G, O’brien T. [ 18 F]-Fluorodeoxyglucose Positron Emission Tomography in the Diagnosis, Treatment Stratification, and Monitoring of Patients with Retroperitoneal Fibrosis: A Prospective Clinical Study. European Urology 2017;71:926-33. [DOI: 10.1016/j.eururo.2016.10.046] [Cited by in Crossref: 27] [Cited by in F6Publishing: 28] [Article Influence: 5.4] [Reference Citation Analysis]
18 Krishnan N, Perazella MA. The Role of PET Scanning in the Evaluation of Patients With Kidney Disease. Adv Chronic Kidney Dis 2017;24:154-61. [PMID: 28501078 DOI: 10.1053/j.ackd.2017.01.002] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.4] [Reference Citation Analysis]
19 Pelkmans LG, Hendriksz TR, Westenend PJ, Vermeer HJ, van Bommel EFH. Elevated serum IgG4 levels in diagnosis and treatment response in patients with idiopathic retroperitoneal fibrosis. Clin Rheumatol. 2017;36:903-912. [PMID: 28105551 DOI: 10.1007/s10067-017-3542-8] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 2.2] [Reference Citation Analysis]
20 Rossi GM, Rocco R, Accorsi Buttini E, Marvisi C, Vaglio A. Idiopathic retroperitoneal fibrosis and its overlap with IgG4-related disease. Intern Emerg Med 2017;12:287-99. [DOI: 10.1007/s11739-016-1599-z] [Cited by in Crossref: 45] [Cited by in F6Publishing: 36] [Article Influence: 9.0] [Reference Citation Analysis]
21 Maritati F, Moroni G, Vaglio A. Retroperitoneal Fibrosis and the Spectrum of Chronic Periaortitis. Systemic Fibroinflammatory Disorders 2017. [DOI: 10.1007/978-3-319-41349-5_8] [Reference Citation Analysis]
22 Kumar R, Karunanithi S, Zhuang H, Alavi A. Assessment of Therapy Response by FDG PET in Infection and Inflammation. PET Clin 2012;7:233-43. [PMID: 27157240 DOI: 10.1016/j.cpet.2012.01.004] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
23 Fofi C, Prosperi D, Pettorini L, Festuccia F, Pirisino R, Lanni V, Scopinaro F, Punzo G, Menè P. Diagnosis and follow-up of idiopathic retroperitoneal fibrosis: role of 18F-FDG-PET/CT and biochemical parameters in patients with renal involvement. Intern Emerg Med 2016;11:809-16. [DOI: 10.1007/s11739-016-1426-6] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
24 Ruhlmann V, Poeppel TD, Brandt AS, Grüneisen J, Ruhlmann M, Theysohn JM, Forsting M, Bockisch A, Umutlu L. (18)F-FDG PET/MRI evaluation of retroperitoneal fibrosis: a simultaneous multiparametric approach for diagnosing active disease. Eur J Nucl Med Mol Imaging 2016;43:1646-52. [PMID: 26969347 DOI: 10.1007/s00259-016-3351-3] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.8] [Reference Citation Analysis]
25 Shiber S, Eliakim-raz N, Yair M. Fibrose retroperitoneal: série de cinco casos e revisão da literatura. Revista Brasileira de Reumatologia 2016;56:101-4. [DOI: 10.1016/j.rbr.2014.09.004] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.2] [Reference Citation Analysis]
26 Vaglio A, Maritati F. Idiopathic Retroperitoneal Fibrosis. J Am Soc Nephrol 2016;27:1880-9. [PMID: 26860343 DOI: 10.1681/ASN.2015101110] [Cited by in Crossref: 83] [Cited by in F6Publishing: 86] [Article Influence: 13.8] [Reference Citation Analysis]
27 Bianchi D. IgG4-related disease: what urologists should know. Int Urol Nephrol 2016;48:301-12. [DOI: 10.1007/s11255-015-1189-4] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 1.2] [Reference Citation Analysis]
28 Lioger B, Yahiaoui Y, Kahn JE, Fakhouri F, Belenfant X, Papo T, Magnant J, Maillot F, Vordos D, Godeau B, Michel M. [Retroperitoneal fibrosis in adults: Main characteristics and relevance of the diagnostic procedures based on a retrospective multicenter study on 77 cases]. Rev Med Interne 2016;37:387-93. [PMID: 26415922 DOI: 10.1016/j.revmed.2015.08.013] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
29 Zhou HJ, Yan Y, Zhou B, Lan TF, Wang XY, Li CS. Retroperitoneal fibrosis: a retrospective clinical data analysis of 30 patients in a 10-year period. Chin Med J (Engl) 2015;128:804-10. [PMID: 25758277 DOI: 10.4103/0366-6999.152648] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 1.9] [Reference Citation Analysis]
30 Kamper L, Haage P, Brandt AS, Piroth W, Abanador-Kamper N, Roth S, Ekamp H. Diffusion-weighted MRI in the follow-up of chronic periaortitis. Br J Radiol 2015;88:20150145. [PMID: 26110205 DOI: 10.1259/bjr.20150145] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.3] [Reference Citation Analysis]
31 Cristian S, Cristian M, Cristian P, Constantin G, Savu C, Huri E, Sinescu I. Management of idiopathic retroperitoneal fibrosis from the urologist's perspective. Ther Adv Urol 2015;7:85-99. [PMID: 25829952 DOI: 10.1177/1756287214565637] [Cited by in Crossref: 16] [Cited by in F6Publishing: 20] [Article Influence: 2.3] [Reference Citation Analysis]
32 Shiber S, Eliakim-Raz N, Yair M. Retroperitoneal fibrosis: case series of five patients and review of the literature. Rev Bras Reumatol Engl Ed 2016;56:101-4. [PMID: 27267521 DOI: 10.1016/j.rbre.2014.09.006] [Cited by in Crossref: 1] [Cited by in F6Publishing: 6] [Article Influence: 0.1] [Reference Citation Analysis]
33 Gaballah AH, Shaaban AM, Elguindy YM, Elsayes KM. The Extraperitoneal Spaces. Cross-Sectional Imaging of the Abdomen and Pelvis 2015. [DOI: 10.1007/978-1-4939-1884-3_17] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
34 Apte AV, Attarde VY, Patil PV, Patil S. CECT FEATURES OF RETROPERITONEAL FIBROSIS WITH BILATERAL OBSTRUCTIVE UROPATHY SECONDARY TO ANEURYSM AND DISSECTION OF ABDOMINAL AORTA. jemds 2014;3:2586-2589. [DOI: 10.14260/jemds/2014/2177] [Reference Citation Analysis]
35 Toriihara A, Tateishi U. Functional Imaging of Tumors of the Mesenterium and Retroperitoneum. Functional Imaging in Oncology 2014. [DOI: 10.1007/978-3-642-40582-2_27] [Reference Citation Analysis]
36 Niccoli Asabella A, Nicoletti A, Altini C, Notaristefano A, Lastilla G, Rubini G. 18F-FDG Positron Emission Tomography/Computed Tomography in the Diagnosis and Post-Therapeutic Treatment in a Patient with an Early Stage of Retroperitoneal Fibrosis. Mol Imaging Radionucl Ther 2013;22:60-2. [PMID: 24003399 DOI: 10.4274/Mirt.140] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
37 Comín JM, Gasén AR, Van de Wiele C. Nuclear Medicine Imaging of Infections and Inflammatory Diseases of the Abdomen. Diagnostic Imaging of Infections and Inflammatory Diseases 2013. [DOI: 10.1002/9781118484388.ch13] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
38 Pipitone N, Vaglio A, Salvarani C. Retroperitoneal fibrosis. Best Pract Res Clin Rheumatol 2012;26:439-48. [PMID: 23040359 DOI: 10.1016/j.berh.2012.07.004] [Cited by in Crossref: 45] [Cited by in F6Publishing: 46] [Article Influence: 5.0] [Reference Citation Analysis]
39 Caiafa RO, Vinuesa AS, Izquierdo RS, Brufau BP, Ayuso Colella JR, Molina CN. Retroperitoneal Fibrosis: Role of Imaging in Diagnosis and Follow-up. RadioGraphics 2013;33:535-52. [DOI: 10.1148/rg.332125085] [Cited by in Crossref: 69] [Cited by in F6Publishing: 74] [Article Influence: 7.7] [Reference Citation Analysis]
40 Sahani DV, Bonaffini PA, Catalano OA, Guimaraes AR, Blake MA. State-of-the-art PET/CT of the pancreas: current role and emerging indications. Radiographics. 2012;32:1133-1358; discussion 1358-1360. [PMID: 22786999 DOI: 10.1148/rg.324115143] [Cited by in Crossref: 73] [Cited by in F6Publishing: 80] [Article Influence: 7.3] [Reference Citation Analysis]
41 Treglia G, Mattoli MV, Bertagna F, Giubbini R, Giordano A. Emerging role of Fluorine-18-fluorodeoxyglucose positron emission tomography in patients with retroperitoneal fibrosis: a systematic review. Rheumatol Int 2013;33:549-55. [PMID: 23124736 DOI: 10.1007/s00296-012-2576-0] [Cited by in Crossref: 17] [Cited by in F6Publishing: 11] [Article Influence: 1.7] [Reference Citation Analysis]
42 Treglia G, Mattoli MV, Bertagna F. Fluorine-18-fluorodeoxyglucose positron emission tomography in assessing retroperitoneal fibrosis: a literature review. Int J Mol Imaging 2012;2012:484052. [PMID: 23050140 DOI: 10.1155/2012/484052] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
43 Moroni G, Castellani M, Balzani A, Dore R, Bonelli N, Longhi S, Martinelli I, Messa P, Gerundini P. The value of (18)F-FDG PET/CT in the assessment of active idiopathic retroperitoneal fibrosis. Eur J Nucl Med Mol Imaging 2012;39:1635-42. [PMID: 22801728 DOI: 10.1007/s00259-012-2144-6] [Cited by in Crossref: 33] [Cited by in F6Publishing: 34] [Article Influence: 3.3] [Reference Citation Analysis]
44 Bertagna F, Treglia G, Leccisotti L, Bosio G, Motta F, Giordano A, Giubbini R. [¹⁸F]FDG-PET/CT in patients affected by retroperitoneal fibrosis: a bicentric experience. Jpn J Radiol 2012;30:415-21. [PMID: 22421932 DOI: 10.1007/s11604-012-0066-7] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 1.1] [Reference Citation Analysis]
45 Pelkmans LG, Aarnoudse AJ, Hendriksz TR, van Bommel EF. Value of acute-phase reactants in monitoring disease activity and treatment response in idiopathic retroperitoneal fibrosis. Nephrol Dial Transplant 2012;27:2819-25. [PMID: 22273666 DOI: 10.1093/ndt/gfr779] [Cited by in Crossref: 31] [Cited by in F6Publishing: 32] [Article Influence: 3.1] [Reference Citation Analysis]
46 Székely H, Hagymási K, Sápi Z, Hartmann E, Mihály E, Muzes G, Tulassay Z. [Idiopathic retroperitoneal fibrosis. Pitfalls and challenges--experience with two cases]. Orv Hetil 2011;152:1818-26. [PMID: 22011369 DOI: 10.1556/OH.2011.29234] [Reference Citation Analysis]
47 Treglia G, Mattoli MV, Leccisotti L, Ferraccioli G, Giordano A. Usefulness of whole-body fluorine-18-fluorodeoxyglucose positron emission tomography in patients with large-vessel vasculitis: a systematic review. Clin Rheumatol 2011;30:1265-75. [PMID: 21833685 DOI: 10.1007/s10067-011-1828-9] [Cited by in Crossref: 74] [Cited by in F6Publishing: 80] [Article Influence: 6.7] [Reference Citation Analysis]
48 Abraham M, Lazareth I, Bonardel G, Albiges L, Dechaud C, Marini V, Michon-Pasturel U, Molinier V, Priollet P. [Kikuchi disease and lupus: case report, literature review and FDG PET/CT interest]. J Mal Vasc 2011;36:274-9. [PMID: 21757306 DOI: 10.1016/j.jmv.2011.05.004] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
49 Mehta A, Blodgett TM. Retroperitoneal fibrosis as a cause of positive FDG PET/CT. J Radiol Case Rep 2011;5:35-41. [PMID: 22470805 DOI: 10.3941/jrcr.v5i7.722] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]